NCT04711993

Brief Summary

Restless leg syndrome (RLS) is a very common neurological condition characterized by an uncontrollable desire to move the legs. Due to the traumatic effect of RLS on morbidity, the patient is negatively affected in many different directions. The duration and quality of sleep of the patients decrease, and their cognitive functions change. The prevalence or risk of anxiety and depression increases in this population. At the same time, the quality of life of patients is significantly reduced. Among the different pharmacological agents used in RLS, dopamine agonists are the most widely used. However, the reporting of serious and common side effects related to this treatment has led to non-pharmacological approaches in the treatment of RLS and the effectiveness of many different approaches has been investigated. The exercise approach, which is determined to be effective in the treatment of the disease, is a subject that has been little studied. The type, duration and frequency of optimal exercise could not be standardized. In addition, the effect of exercise on RLS patients has been investigated in limited subjects. For this reason, the aim of our study is to examine the effect of different exercise programs on symptoms, sleep, cognitive functions, quality of life, psychological status and fatigue in patients with RLS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 11, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 15, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

February 17, 2021

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 17, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 17, 2022

Completed
Last Updated

December 19, 2022

Status Verified

December 1, 2022

Enrollment Period

1.5 years

First QC Date

January 11, 2021

Last Update Submit

December 15, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in Symptoms

    The severity of the symptoms of the patients will be evaluated with the International Restless Legs Syndrome Study Group Rating Scale. It is a 10-item questionnaire developed through expert evaluation of potential items. Scoring varies between 0-40. The higher the score indicates higher symptoms.

    Before treatment, after treatment (end of 8 weeks)

  • Change in Sleep

    the patient will be asked to sleep by wearing watches that detect movement (movement watch) for 3 nights, one of which is fixed on the metatarsal and the other is fixed on the wrist. While the objective test of sleep is performed with the software compatible with the wrist watch, periodic extremity movements will be recorded with the software compatible with the other watch.

    Before treatment, after treatment (end of 8 weeks)

  • Change in Sleepiness

    Epworth Sleepiness Scale(ESS) will be used. Its score (the sum of 8 item scores, 0-3) can range from 0 to 24. The higher the ESS score, the higher that person's average sleep propensity in daily life (ASP), or their 'daytime

    Before treatment, after treatment (end of 8 weeks)

  • Change in Sleep Quality

    Pittsburgh Sleep Quality Index will be used.Pittsburgh Sleep Quality Index scale has seven sub-scales that portray various domains of sleep: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction. Responses for each subscale are scored as 0-3. Having a global score of 5 or higher indicates bad sleep quality. sleepiness.

    Before treatment, after treatment (end of 8 weeks)

Secondary Outcomes (5)

  • Change in Psychological status

    Before treatment, after treatment (end of 8 weeks)

  • Change in Quality of life in RLS

    Before treatment, after treatment (end of 8 weeks)

  • Change in Fatigue

    Before treatment, after treatment (end of 8 weeks)

  • Change in Gastrointestinal symptoms

    Before treatment, after treatment (end of 8 weeks)

  • Change in Cognitive function

    Before treatment, after treatment (end of 8 weeks)

Study Arms (3)

Control group

NO INTERVENTION

No application will be made to the control group. However, these patients will be included in the exercise program they want after the 8-week treatment period is completed.

Aerobic exercise group

EXPERIMENTAL

Patients in the aerobic exercise group will exercise under the supervision of the therapist.

Other: Aerobic exercise

Stretching exercise group

EXPERIMENTAL

Patients in the stretching-mobility exercise group will do stretching exercises under the supervision of the therapist

Other: Stretchin exercise

Interventions

Patients will do aerobic exercise three days a week for 40 minutes during 8 weeks. Aerobic exercise protocol will consist of warm up, loading and cooling periods. . Exercise prescription will be prepared in line with the recommendations of "The American College of Sports Medicine".

Aerobic exercise group

Patients will do stretching exercise three days a week for 40 minutes during 8 weeks. Stretching exercises will start with active warm-up activities. Static stretching method will be used.

Stretching exercise group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Having been diagnosed with RLS according to the International Restless Legs Syndrome Study Group 2014 criteria
  • Being over the age of 18
  • Being literate
  • Not having received any treatment for RLS, discontinuing treatment, or continuing symptoms despite current treatment.

You may not qualify if:

  • Having any of musculoskeletal disorders that prevent physical activity
  • History of ischemic heart disease (recent myocardial infarction or unstable angina, uncontrolled hypertension)
  • Liver dysfunction
  • Kidney dysfunction
  • Anemia
  • Diagnosis of another sleep disorder
  • Diagnosis of gastrointestinal disease (irritable bowel syndrome, Crohn's disease, ulcerative colitis etc.)
  • Pregnancy
  • History of psychiatric, psychoactive, antidepressant medication use
  • History of malignancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gulhane Health Science Faculty

Ankara, 06018, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Restless Legs SyndromeAnxiety Disorders

Interventions

Exercise

Condition Hierarchy (Ancestors)

Nervous System DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersParasomniasMental Disorders

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigation of the effects of different exercise programs on symptoms, sleep, cognitive functions, fatigue, quality of life, and psychological status in patients with restless legs syndrome.

Study Record Dates

First Submitted

January 11, 2021

First Posted

January 15, 2021

Study Start

February 17, 2021

Primary Completion

August 17, 2022

Study Completion

September 17, 2022

Last Updated

December 19, 2022

Record last verified: 2022-12

Locations